Mutations in SCN5A can alter both the magnitude and the shape of INa, which – in conjunction with other factors – can predispose carriers to clinical phenotypes including Brugada syndrome, long-QT syndrome, and conduction disorders2. This evidence concerns the gene SCN5A and Prolonged QT interval.